tradmap

HNGE Financials Hinge Health, Inc.

3 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 41.7% per year over the past 2 years.
  • Operating margin has contracted, at -92.9% in the latest year.
Revenue & net income
-$528M $30M $588M $0 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
-93% -7% 80% 0% 2023 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
-$66M $52M $171M $0 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $150M $301M 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$150M $10M $171M $0 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $588M -$528M 79.6% -92.9% $171M $208M
2024 $390M -$12M 76.8% -8.2% $48M $301M
2023 $293M -$108M 66.3% -44.6% -$66M $235M

Valuation over time

How the market has priced HNGE against its own fundamentals since 2025-05 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 5.7 11.3 May '25 Jul '25 Sep '25 Nov '25 Jan '26 Mar '26 May '26
P/S

Frequently asked questions

Is HNGE growing its revenue and profit?

Over the past 2 years, Hinge Health, Inc.'s revenue has grown 41.7% per year. These are computed facts, not advice.

How much debt does HNGE have?

As of FY2025, Hinge Health, Inc. reported — of total debt against $208M of cash.

What is HNGE's profit margin?

In FY2025, gross margin was 79.6%, operating margin -92.9%, and net margin -89.9%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.